Annual CFO
$13.01 B
-$6.09 B-31.89%
31 December 2023
Summary:
Merck & Co annual cash flow from operations is currently $13.01 billion, with the most recent change of -$6.09 billion (-31.89%) on 31 December 2023. During the last 3 years, it has risen by +$2.75 billion (+26.85%). MRK annual CFO is now -31.89% below its all-time high of $19.09 billion, reached on 31 December 2022.MRK Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$9.29 B
+$3.65 B+64.82%
30 September 2024
Summary:
Merck & Co quarterly cash flow from operations is currently $9.29 billion, with the most recent change of +$3.65 billion (+64.82%) on 30 September 2024. Over the past year, it has increased by +$1.57 billion (+20.40%). MRK quarterly CFO is now at all-time high.MRK Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$18.26 B
+$1.57 B+9.43%
30 September 2024
Summary:
Merck & Co TTM cash flow from operations is currently $18.26 billion, with the most recent change of +$1.57 billion (+9.43%) on 30 September 2024. Over the past year, it has increased by +$1.07 billion (+6.25%). MRK TTM CFO is now -7.27% below its all-time high of $19.70 billion, reached on 30 September 2022.MRK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRK Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.9% | +20.4% | +6.3% |
| 3 y3 years | +26.9% | +93.7% | +39.6% |
| 5 y5 years | +19.1% | +119.8% | +49.2% |
MRK Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -31.9% | +26.9% | at high | +3676.8% | -7.3% | +40.4% |
| 5 y | 5 years | -31.9% | +26.9% | at high | +3676.8% | -7.3% | +78.1% |
| alltime | all time | -31.9% | +842.0% | at high | +799.1% | -7.3% | +3468.6% |
Merck & Co Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.29 B(+64.8%) | $18.26 B(+9.4%) |
| June 2024 | - | $5.64 B(+82.4%) | $16.69 B(+13.1%) |
| Mar 2024 | - | $3.09 B(+1156.1%) | $14.76 B(+13.5%) |
| Dec 2023 | $13.01 B(-31.9%) | $246.00 M(-96.8%) | $13.01 B(-24.3%) |
| Sept 2023 | - | $7.72 B(+108.3%) | $17.19 B(+14.0%) |
| June 2023 | - | $3.70 B(+176.6%) | $15.07 B(-3.8%) |
| Mar 2023 | - | $1.34 B(-69.8%) | $15.67 B(-17.9%) |
| Dec 2022 | $19.09 B(+35.3%) | $4.43 B(-20.9%) | $19.09 B(-3.1%) |
| Sept 2022 | - | $5.60 B(+30.2%) | $19.70 B(+4.3%) |
| June 2022 | - | $4.30 B(-9.6%) | $18.89 B(+10.6%) |
| Mar 2022 | - | $4.76 B(-5.4%) | $17.08 B(+21.1%) |
| Dec 2021 | $14.11 B(+37.6%) | $5.03 B(+4.9%) | $14.11 B(+7.8%) |
| Sept 2021 | - | $4.80 B(+92.7%) | $13.08 B(+25.1%) |
| June 2021 | - | $2.49 B(+39.0%) | $10.46 B(-7.7%) |
| Mar 2021 | - | $1.79 B(-55.3%) | $11.34 B(+10.6%) |
| Dec 2020 | $10.25 B(-23.7%) | $4.01 B(+84.4%) | $10.25 B(-7.1%) |
| Sept 2020 | - | $2.17 B(-35.5%) | $11.04 B(-15.7%) |
| June 2020 | - | $3.37 B(+376.2%) | $13.09 B(+2.2%) |
| Mar 2020 | - | $707.00 M(-85.3%) | $12.81 B(-4.7%) |
| Dec 2019 | $13.44 B(+23.1%) | $4.79 B(+13.4%) | $13.44 B(+9.8%) |
| Sept 2019 | - | $4.23 B(+37.0%) | $12.24 B(+13.3%) |
| June 2019 | - | $3.08 B(+130.8%) | $10.80 B(-2.7%) |
| Mar 2019 | - | $1.34 B(-62.8%) | $11.10 B(+1.7%) |
| Dec 2018 | $10.92 B(+69.3%) | $3.59 B(+28.6%) | $10.92 B(-3.8%) |
| Sept 2018 | - | $2.79 B(-17.4%) | $11.35 B(+53.7%) |
| June 2018 | - | $3.38 B(+192.8%) | $7.38 B(+0.9%) |
| Mar 2018 | - | $1.16 B(-71.3%) | $7.32 B(+13.5%) |
| Dec 2017 | $6.45 B(-37.8%) | $4.02 B(-443.2%) | $6.45 B(+6.4%) |
| Sept 2017 | - | -$1.17 B(-135.3%) | $6.06 B(-40.6%) |
| June 2017 | - | $3.32 B(+1059.8%) | $10.21 B(+20.2%) |
| Mar 2017 | - | $286.00 M(-92.1%) | $8.49 B(-18.2%) |
| Dec 2016 | $10.38 B(-17.2%) | $3.63 B(+22.2%) | $10.38 B(-5.6%) |
| Sept 2016 | - | $2.97 B(+85.7%) | $10.99 B(-3.0%) |
| June 2016 | - | $1.60 B(-26.4%) | $11.33 B(-8.8%) |
| Mar 2016 | - | $2.17 B(-48.8%) | $12.43 B(-0.9%) |
| Dec 2015 | $12.54 B(+56.9%) | $4.25 B(+28.2%) | $12.54 B(+72.8%) |
| Sept 2015 | - | $3.31 B(+22.8%) | $7.26 B(-12.5%) |
| June 2015 | - | $2.70 B(+18.1%) | $8.29 B(+4.8%) |
| Mar 2015 | - | $2.28 B(-320.7%) | $7.91 B(-1.0%) |
| Dec 2014 | $7.99 B(-31.4%) | -$1.03 B(-123.8%) | $7.99 B(-33.7%) |
| Sept 2014 | - | $4.35 B(+87.8%) | $12.05 B(+3.4%) |
| June 2014 | - | $2.31 B(-1.9%) | $11.65 B(-0.2%) |
| Mar 2014 | - | $2.36 B(-22.0%) | $11.67 B(+0.2%) |
| Dec 2013 | $11.65 B(+16.3%) | $3.03 B(-23.4%) | $11.65 B(+11.7%) |
| Sept 2013 | - | $3.95 B(+68.9%) | $10.44 B(+8.4%) |
| June 2013 | - | $2.34 B(-0.1%) | $9.63 B(-5.7%) |
| Mar 2013 | - | $2.34 B(+29.4%) | $10.21 B(+1.9%) |
| Dec 2012 | $10.02 B(-19.1%) | $1.81 B(-42.4%) | $10.02 B(-12.4%) |
| Sept 2012 | - | $3.14 B(+7.5%) | $11.45 B(-11.2%) |
| June 2012 | - | $2.92 B(+35.6%) | $12.88 B(+0.5%) |
| Mar 2012 | - | $2.15 B(-33.4%) | $12.82 B(+3.5%) |
| Dec 2011 | $12.38 B(+14.4%) | $3.23 B(-29.4%) | $12.38 B(-2.4%) |
| Sept 2011 | - | $4.58 B(+60.5%) | $12.69 B(+18.5%) |
| June 2011 | - | $2.85 B(+65.7%) | $10.70 B(-4.2%) |
| Mar 2011 | - | $1.72 B(-51.4%) | $11.18 B(+3.3%) |
| Dec 2010 | $10.82 B(+219.0%) | $3.54 B(+36.5%) | $10.82 B(+13.6%) |
| Sept 2010 | - | $2.59 B(-22.0%) | $9.53 B(+43.9%) |
| June 2010 | - | $3.33 B(+143.4%) | $6.62 B(+63.7%) |
| Mar 2010 | - | $1.37 B(-39.1%) | $4.05 B(+19.3%) |
| Dec 2009 | $3.39 B(-48.4%) | $2.24 B(-818.5%) | $3.39 B(+57.0%) |
| Sept 2009 | - | -$312.10 M(-141.7%) | $2.16 B(-47.6%) |
| June 2009 | - | $749.00 M(+5.1%) | $4.12 B(-13.3%) |
| Mar 2009 | - | $712.60 M(-29.5%) | $4.76 B(-27.6%) |
| Dec 2008 | $6.57 B(-6.1%) | $1.01 B(-38.8%) | $6.57 B(-16.9%) |
| Sept 2008 | - | $1.65 B(+19.7%) | $7.91 B(-14.8%) |
| June 2008 | - | $1.38 B(-45.4%) | $9.28 B(-14.5%) |
| Mar 2008 | - | $2.53 B(+7.7%) | $10.86 B(+55.1%) |
| Dec 2007 | $7.00 B | $2.35 B(-22.4%) | $7.00 B(+8.9%) |
| Sept 2007 | - | $3.03 B(+2.4%) | $6.43 B(+31.6%) |
| June 2007 | - | $2.95 B(-322.3%) | $4.88 B(+18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$1.33 B(-174.8%) | $4.13 B(-39.0%) |
| Dec 2006 | $6.77 B(-11.1%) | $1.78 B(+19.9%) | $6.77 B(-6.7%) |
| Sept 2006 | - | $1.48 B(-32.7%) | $7.25 B(-9.3%) |
| June 2006 | - | $2.20 B(+68.4%) | $8.00 B(+5.6%) |
| Mar 2006 | - | $1.31 B(-42.3%) | $7.58 B(-0.4%) |
| Dec 2005 | $7.61 B(-13.5%) | $2.26 B(+1.7%) | $7.61 B(-1.3%) |
| Sept 2005 | - | $2.23 B(+25.4%) | $7.71 B(-0.4%) |
| June 2005 | - | $1.78 B(+32.6%) | $7.74 B(-7.0%) |
| Mar 2005 | - | $1.34 B(-43.4%) | $8.32 B(-5.4%) |
| Dec 2004 | $8.80 B(-10.8%) | $2.37 B(+5.0%) | $8.80 B(-5.0%) |
| Sept 2004 | - | $2.25 B(-4.5%) | $9.26 B(-12.6%) |
| June 2004 | - | $2.36 B(+30.2%) | $10.59 B(+7.3%) |
| Mar 2004 | - | $1.81 B(-35.9%) | $9.87 B(+0.1%) |
| Dec 2003 | $9.86 B(+6.2%) | $2.83 B(-21.2%) | $9.86 B(+0.9%) |
| Sept 2003 | - | $3.59 B(+118.7%) | $9.78 B(+7.6%) |
| June 2003 | - | $1.64 B(-9.3%) | $9.09 B(-0.3%) |
| Mar 2003 | - | $1.81 B(-34.1%) | $9.12 B(-1.8%) |
| Dec 2002 | $9.29 B(+11.3%) | $2.74 B(-5.3%) | $9.29 B(+6.7%) |
| Sept 2002 | - | $2.90 B(+73.4%) | $8.70 B(+1.0%) |
| June 2002 | - | $1.67 B(-15.2%) | $8.62 B(+5.9%) |
| Mar 2002 | - | $1.97 B(-8.8%) | $8.14 B(-2.4%) |
| Dec 2001 | $8.34 B(+8.5%) | $2.16 B(-23.2%) | $8.34 B(-0.5%) |
| Sept 2001 | - | $2.81 B(+135.7%) | $8.38 B(+14.9%) |
| June 2001 | - | $1.19 B(-45.0%) | $7.30 B(-6.2%) |
| Mar 2001 | - | $2.17 B(-1.3%) | $7.78 B(+1.2%) |
| Dec 2000 | $7.69 B(+25.4%) | $2.20 B(+27.3%) | $7.69 B(+12.6%) |
| Sept 2000 | - | $1.73 B(+3.3%) | $6.83 B(+2.7%) |
| June 2000 | - | $1.67 B(-19.7%) | $6.65 B(+6.4%) |
| Mar 2000 | - | $2.08 B(+55.5%) | $6.25 B(+1.9%) |
| Dec 1999 | $6.13 B(+15.1%) | $1.34 B(-13.6%) | $6.13 B(+1.3%) |
| Sept 1999 | - | $1.55 B(+21.9%) | $6.05 B(+1.1%) |
| June 1999 | - | $1.27 B(-35.4%) | $5.99 B(+3.8%) |
| Mar 1999 | - | $1.97 B(+55.7%) | $5.77 B(+8.3%) |
| Dec 1998 | $5.33 B(-15.6%) | $1.26 B(-15.0%) | $5.33 B(-11.5%) |
| Sept 1998 | - | $1.49 B(+41.2%) | $6.02 B(-2.7%) |
| June 1998 | - | $1.05 B(-30.9%) | $6.19 B(-2.5%) |
| Mar 1998 | - | $1.52 B(-22.0%) | $6.35 B(+0.5%) |
| Dec 1997 | $6.32 B(+16.4%) | $1.96 B(+18.3%) | $6.32 B(+1.0%) |
| Sept 1997 | - | $1.65 B(+36.2%) | $6.26 B(+6.9%) |
| June 1997 | - | $1.21 B(-18.7%) | $5.85 B(+2.0%) |
| Mar 1997 | - | $1.49 B(-21.2%) | $5.74 B(+5.7%) |
| Dec 1996 | $5.43 B(+84.4%) | $1.90 B(+52.0%) | $5.43 B(+15.9%) |
| Sept 1996 | - | $1.25 B(+13.2%) | $4.68 B(+6.1%) |
| June 1996 | - | $1.10 B(-6.9%) | $4.42 B(+17.7%) |
| Mar 1996 | - | $1.18 B(+2.7%) | $3.75 B(+27.4%) |
| Dec 1995 | $2.94 B(-28.9%) | $1.15 B(+17.9%) | $2.94 B(+5.3%) |
| Sept 1995 | - | $977.40 M(+122.9%) | $2.80 B(-11.0%) |
| June 1995 | - | $438.40 M(+16.6%) | $3.14 B(-18.1%) |
| Mar 1995 | - | $376.10 M(-62.5%) | $3.83 B(-7.4%) |
| Dec 1994 | $4.14 B(+35.8%) | $1.00 B(-24.1%) | $4.14 B(+2.2%) |
| Sept 1994 | - | $1.32 B(+16.7%) | $4.05 B(+8.6%) |
| June 1994 | - | $1.13 B(+66.0%) | $3.73 B(+22.6%) |
| Mar 1994 | - | $682.20 M(-25.5%) | $3.04 B(-0.2%) |
| Dec 1993 | $3.05 B(+21.7%) | $915.70 M(-8.6%) | $3.05 B(+3.3%) |
| Sept 1993 | - | $1.00 B(+125.7%) | $2.95 B(+9.6%) |
| June 1993 | - | $443.90 M(-35.4%) | $2.69 B(+1.5%) |
| Mar 1993 | - | $687.10 M(-16.0%) | $2.65 B(+6.0%) |
| Dec 1992 | $2.50 B(+2.9%) | $817.90 M(+9.9%) | $2.50 B(+3.6%) |
| Sept 1992 | - | $743.90 M(+83.6%) | $2.42 B(+0.6%) |
| June 1992 | - | $405.20 M(-24.6%) | $2.40 B(+4.0%) |
| Mar 1992 | - | $537.40 M(-26.4%) | $2.31 B(-5.1%) |
| Dec 1991 | $2.43 B(+18.4%) | $730.50 M(+0.2%) | $2.43 B(+4.6%) |
| Sept 1991 | - | $729.10 M(+133.5%) | $2.33 B(+9.9%) |
| June 1991 | - | $312.20 M(-52.9%) | $2.12 B(-4.0%) |
| Mar 1991 | - | $662.20 M(+6.0%) | $2.21 B(+7.3%) |
| Dec 1990 | $2.06 B(+48.9%) | $624.50 M(+20.3%) | $2.06 B(+43.6%) |
| Sept 1990 | - | $519.30 M(+29.8%) | $1.43 B(+57.0%) |
| June 1990 | - | $400.00 M(-21.8%) | $911.80 M(+78.2%) |
| Mar 1990 | - | $511.80 M | $511.80 M |
| Dec 1989 | $1.38 B | - | - |
FAQ
- What is Merck & Co annual cash flow from operations?
- What is the all time high annual CFO for Merck & Co?
- What is Merck & Co annual CFO year-on-year change?
- What is Merck & Co quarterly cash flow from operations?
- What is the all time high quarterly CFO for Merck & Co?
- What is Merck & Co quarterly CFO year-on-year change?
- What is Merck & Co TTM cash flow from operations?
- What is the all time high TTM CFO for Merck & Co?
- What is Merck & Co TTM CFO year-on-year change?
What is Merck & Co annual cash flow from operations?
The current annual CFO of MRK is $13.01 B
What is the all time high annual CFO for Merck & Co?
Merck & Co all-time high annual cash flow from operations is $19.09 B
What is Merck & Co annual CFO year-on-year change?
Over the past year, MRK annual cash flow from operations has changed by -$6.09 B (-31.89%)
What is Merck & Co quarterly cash flow from operations?
The current quarterly CFO of MRK is $9.29 B
What is the all time high quarterly CFO for Merck & Co?
Merck & Co all-time high quarterly cash flow from operations is $9.29 B
What is Merck & Co quarterly CFO year-on-year change?
Over the past year, MRK quarterly cash flow from operations has changed by +$1.57 B (+20.40%)
What is Merck & Co TTM cash flow from operations?
The current TTM CFO of MRK is $18.26 B
What is the all time high TTM CFO for Merck & Co?
Merck & Co all-time high TTM cash flow from operations is $19.70 B
What is Merck & Co TTM CFO year-on-year change?
Over the past year, MRK TTM cash flow from operations has changed by +$1.07 B (+6.25%)